Society
Combining two drugs doubles survival chances for kidney cancer patients… A study reveals the details
WHAT TO KNOW
Lebanon 24: Data from a mid-stage clinical trial revealed that combining two drugs in the “targeted therapy” class may significantly improve survival chances for some patients with newly diagnosed advanced kidney cancer. The trial was conducted on 51 patients, all of whom had kidney cancer of the…
Machine translation of an attributed source excerpt. Consult the original report to verify details. Translated from original reporting in another language.
